Cargando…

Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial

OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histo...

Descripción completa

Detalles Bibliográficos
Autores principales: Coudert, Jerome D, Slater, Nataliya, Sooda, Anuradha, Beer, Kelly, Lim, Ee Mun, Boyder, Conchita, Zhang, Rui, Mastaglia, Frank L, Learmonth, Yvonne C, Fairchild, Timothy J, Yeap, Bu B, Needham, Merrilee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495304/
https://www.ncbi.nlm.nih.gov/pubmed/36188123
http://dx.doi.org/10.1002/cti2.1416
_version_ 1784793984768409600
author Coudert, Jerome D
Slater, Nataliya
Sooda, Anuradha
Beer, Kelly
Lim, Ee Mun
Boyder, Conchita
Zhang, Rui
Mastaglia, Frank L
Learmonth, Yvonne C
Fairchild, Timothy J
Yeap, Bu B
Needham, Merrilee
author_facet Coudert, Jerome D
Slater, Nataliya
Sooda, Anuradha
Beer, Kelly
Lim, Ee Mun
Boyder, Conchita
Zhang, Rui
Mastaglia, Frank L
Learmonth, Yvonne C
Fairchild, Timothy J
Yeap, Bu B
Needham, Merrilee
author_sort Coudert, Jerome D
collection PubMed
description OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histocompatibility complex molecules and invaded by CD8(+) T cells and macrophages, and by degenerative changes including protein aggregates organised in inclusion bodies, rimmed vacuoles and mitochondrial abnormalities. There is currently no cure, and regular exercise is currently the only recognised treatment effective at limiting muscle weakening, atrophy and loss of function. Testosterone exerts anti‐inflammatory effects, inhibiting effector T‐cell differentiation and pro‐inflammatory cytokine production. METHODS: We conducted a double‐blind, placebo‐controlled, cross‐over trial in men with IBM, to assess whether a personalised progressive exercise training combined with application of testosterone, reduced the inflammatory immune response associated with this disease over and above exercise alone. To assess intervention efficacy, we immunophenotyped blood immune cells by flow cytometry, and measured serum cytokines and chemokines by Luminex immunoassay. RESULTS: Testosterone supplementation resulted in modest yet significant count reduction in the classical monocyte subset as well as eosinophils. Testosterone‐independent immunoregulatory effects attributed to exercise included altered proportions of some monocyte, T‐ and B‐cell subsets, and reduced IL‐12, IL‐17, TNF‐α, MIP‐1β and sICAM‐1 in spite of interindividual variability. CONCLUSION: Overall, our findings indicate anti‐inflammatory effects of exercise training in IBM patients, whilst concomitant testosterone supplementation provides some additional changes. Further studies combining testosterone and exercise would be worthwhile in larger cohorts and longer testosterone administration periods.
format Online
Article
Text
id pubmed-9495304
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94953042022-09-30 Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial Coudert, Jerome D Slater, Nataliya Sooda, Anuradha Beer, Kelly Lim, Ee Mun Boyder, Conchita Zhang, Rui Mastaglia, Frank L Learmonth, Yvonne C Fairchild, Timothy J Yeap, Bu B Needham, Merrilee Clin Transl Immunology Original Articles OBJECTIVES: Sporadic Inclusion Body Myositis (IBM) is an inflammatory muscle disease affecting individuals over the age of 45, leading to progressive muscle wasting, disability and loss of independence. Histologically, IBM is characterised by immune changes including myofibres expressing major histocompatibility complex molecules and invaded by CD8(+) T cells and macrophages, and by degenerative changes including protein aggregates organised in inclusion bodies, rimmed vacuoles and mitochondrial abnormalities. There is currently no cure, and regular exercise is currently the only recognised treatment effective at limiting muscle weakening, atrophy and loss of function. Testosterone exerts anti‐inflammatory effects, inhibiting effector T‐cell differentiation and pro‐inflammatory cytokine production. METHODS: We conducted a double‐blind, placebo‐controlled, cross‐over trial in men with IBM, to assess whether a personalised progressive exercise training combined with application of testosterone, reduced the inflammatory immune response associated with this disease over and above exercise alone. To assess intervention efficacy, we immunophenotyped blood immune cells by flow cytometry, and measured serum cytokines and chemokines by Luminex immunoassay. RESULTS: Testosterone supplementation resulted in modest yet significant count reduction in the classical monocyte subset as well as eosinophils. Testosterone‐independent immunoregulatory effects attributed to exercise included altered proportions of some monocyte, T‐ and B‐cell subsets, and reduced IL‐12, IL‐17, TNF‐α, MIP‐1β and sICAM‐1 in spite of interindividual variability. CONCLUSION: Overall, our findings indicate anti‐inflammatory effects of exercise training in IBM patients, whilst concomitant testosterone supplementation provides some additional changes. Further studies combining testosterone and exercise would be worthwhile in larger cohorts and longer testosterone administration periods. John Wiley and Sons Inc. 2022-09-22 /pmc/articles/PMC9495304/ /pubmed/36188123 http://dx.doi.org/10.1002/cti2.1416 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Coudert, Jerome D
Slater, Nataliya
Sooda, Anuradha
Beer, Kelly
Lim, Ee Mun
Boyder, Conchita
Zhang, Rui
Mastaglia, Frank L
Learmonth, Yvonne C
Fairchild, Timothy J
Yeap, Bu B
Needham, Merrilee
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title_full Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title_fullStr Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title_full_unstemmed Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title_short Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial
title_sort immunoregulatory effects of testosterone supplementation combined with exercise training in men with inclusion body myositis: a double‐blind, placebo‐controlled, cross‐over trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495304/
https://www.ncbi.nlm.nih.gov/pubmed/36188123
http://dx.doi.org/10.1002/cti2.1416
work_keys_str_mv AT coudertjeromed immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT slaternataliya immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT soodaanuradha immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT beerkelly immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT limeemun immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT boyderconchita immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT zhangrui immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT mastagliafrankl immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT learmonthyvonnec immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT fairchildtimothyj immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT yeapbub immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial
AT needhammerrilee immunoregulatoryeffectsoftestosteronesupplementationcombinedwithexercisetraininginmenwithinclusionbodymyositisadoubleblindplacebocontrolledcrossovertrial